ABSTRACT The uptake of free choline by isolated perfused rat liver was characterized. A saturable uptake mechanism [Ka = 0.17 ± 0.07 mM (SD); Vm.x = 0.84 i 0.16 gmol/min X g dry weight] and a nonsaturable mechanism (through which uptake is proportional to choline concentration in the perfusate) were identified. Most of the choline transported into hepatocytes was converted to betaine, phosphorylcholine, or lecithin. Free choline also accumulated within the intracellular space, suggesting that choline oxidase activity does not always limit choline's uptake by the liver. Choline, in the form of the phospholipid lecithin, is an integral component of all membranes and an important constituent of the diet. The intake of choline in the United States usually varies between 100 and 600 mg per day (1). Moreover, pharmacologic doses (grams) of choline and lecithin are administered to humans to treat some neurological diseases presumably arising from deficient central cholinergic tone (2). The basis for this therapy is the finding that plasma choline concentration directly influences acetylcholine synthesis and release in rat brain (3, 4) . The increases in plasma choline concentrations seen after oral (3-5) or intravenous (6-8) administration of a large choline dose are small and of short duration. This suggests that highcapacity mechanisms must exist for clearing choline from the blood. The characterization of such mechanisms should be useful in deciding how best to administer choline.
. During each 2-hr perfusion experiment, livers were exposed to one, two, or three different initial [methyl-14C]choline (40,000 dpm/,umol) concentrations. When more than one concentration was used, the second and third were, respectively, 10 and 100 times the first. The initial amount of choline was added to the perfusate at 30 min, with subsequent amounts added at 30-min intervals. The peak choline concentrations achieved in this series of experiments ranged from 0.02 to 5 mM. During the 30 min after each choline administration, samples of perfusate were withdrawn at 3-or 5-min intervals. After 120 min, the liver was removed and quick-frozen (20) ; the perfusate was recirculated in the apparatus for an additional 15 min in order to check for choline disappearance not mediated by the liver.
Radioactivity of perfusate samples was measured in a Beckman LS7000 liquid scintillation counter. Choline was assayed in an aliquot of the same samples by a radioenzymatic assay with choline kinase and [y-32P]ATP (21) .
Metabolite Determinations. In six of the perfusions, aliquots of perfusate and quick-frozen liver specimens were digested in 2 ml of NCS tissue solubilizer (Amersham) at 50°C overnight, and radioactivity was determined in 15 ml of BetaFluor (National Diagnostics, South Somerville, NJ). Other aliquots were extracted in chloroform/methanol/water, 1:1:1 (vol/vol/vol). The aqueous phase was subjected to paper electrophoresis (22) , which separated betaine, choline, and phosphorylcholine. The organic phase was chromatographed on a silica gel plate (Whatman LK5D) with chloroform/methanol/water, 65:30:4 (vol/vol/vol), which separated lecithin, lysolecithin, and sphingomyelin. In both electrophoresis and chromatography, internal standards stained with iodine vapor were used to identify radioactive compounds. Bands were eluted into scintillation vials and radioactivity was determined in 15 ml of Scinti-Verse (Fisher).
Open-Circuit Perfusions. Five livers were perfused at 50 ml/min without recirculation of an albumin-free perfusate. At 15 min, a 10-ml bolus containing [methyl-3H]choline (1 mM; 58,000 dpm/nmol) and [carboxyl-'4C]inulin (0.5 mCi/184 mg; 1 Ci = 3.7 X 1010 becquerels) was infused via a syringe pump into the portal vein perfusion line over 4 min. During this infusion, biopsies of liver specimens were taken at 1, 2, 3, and
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4 min and quick-frozen (20) . The concentration of intracellular labeled choline was calculated by deducting the amount of extracellular choline present in the inulin distribution volume from the total amount of labeled choline found in liver samples.
In Situ Perfusions. In situ short-term liver perfusions without recirculation were performed in fed rats anesthesized with 40 mg of Nembutal per kg (Abbott) and heparinized with 100 units of heparin (Eli Lilly) intravenously. The portal vein was cannulated and the liver was flushed with 20 ml of oxygenated Krebs-Ringer bicarbonate buffer over 1 min. This was followed immediately by 10 ml of the same buffer containing 1 mM [methyl-14C]choline (2.8 X 105 dpm/,tmol) and 15 ,gCi of [G-3H]inulin (0.5 mCi/mg). Immediately thereafter a lobe of liver was excised and quick-frozen between aluminum blocks that had been cooled in liquid N2 (20) . An aliquot of the frozen liver was digested in NCS tissue solubilizer at 500C overnight, and radioactivity was measured in 15 ml of BetaFluor. A second portion of the liver was extracted in chloroform/methanol/ water and subjected to electrophoresis and chromatography as described above.
RESULTS
Perfusate choline concentrations, measured radioenzymatically or calculated from the radioactivity of the perfusate (dpm/ml divided by the specific activity of the injected [methyl-'4C]-choline), were identical (linear regression slope = 1.00, P < 0.01). Electrophoresis and chromatography of selected perfusate samples showed that 90-95% of the radioactivity could be recovered as free choline. No detectable choline was released into the perfusate during the initial 30 min of equilibration. There was no decrease in choline concentration after removal of the liver from the apparatus.
During the first 15 min after addition of labeled substrate to the perfusate, the uptake of choline was approximately linear. The concentrations of choline at midpoints of these initial periods and the slopes of the corresponding linear approximations were used as data points in Fig. 1 
and the other nonsaturable and linear. The hyperbola was characterized statistically by two methods, both of which yielded similar Michaelis-Menten constants.
(i) The first method was the use of repetitive iterations of the difference between observed uptake and the linear component by using direct hyperbolic regression fitting with weighting of 1/variance as described by Wilkinson (23) . By this method the saturable component had a Ka = 0.13 mM + 0.05 (SEM) for choline and a Vmax = 0.69 ,imol/min X g dry weight + 0.05 (SEM). The nonsaturable component had a slope of 0. 26 ,jmol/min X g dry weight (calculated by linear regression, r =0.8960; P <0.01).
(ii) The second method was the use of nonlinear regression analysis (24) concentrations of choline (0.02-0.125 mM), 90% of the radioactivity within the liver was accounted for by choline, betaine, phosphorylcholine, and lecithin ( Fig. 2A ). After perfusions with high initial concentrations of choline (2.5-4.5 mM), the radioactivity was found in the same metabolites, though relatively more was found in betaine (Fig. 2B) .
In five open-circuit perfusion experiments, intracellular accumulation of choline-derived label was calculated by inulin determination of extracellular space. Liver uptake of choline calculated by this method agreed well with uptake calculated by choline's disappearance from perfusate (see Fig. 1 ). (26) and choline oxidase (27) , respectively.
It has been suggested that choline uptake into the liver is directly linked to choline oxidase activity (14) . If the degradation of choline were rate limiting for choline's uptake into the cell, then no free choline should ever accumulate in liver.
We found that labeled free choline does accumulate in amounts that compare in magnitude to those previously reported for total free choline in liver (50-350 nmol/g) (28, 29) . It may be that free choline accumulates only at high perfusing choline concentrations, when the linear uptake mechanism makes a significant contribution to the process. Thus the possibility remains that the saturable choline uptake mechanism is in some way linked to oxidase activity. The liver's ample ability to act as a sink for choline can explain the rapid clearance of administered choline from plasma. 
